Navigation Links
Cynosure Announces Schedule of Upcoming Investor Conferences

WESTFORD, Mass., June 3 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker will discuss the company's business outlook, growth strategy and recent financial results at the following investor conferences this month:

-- On Thursday, June 12, the company will present at the 7th Annual

Needham & Company Biotechnology and Medical Technology Conference in

New York City. The presentation is scheduled to begin at 10:00 a.m.


-- On Wednesday, June 25, Cynosure will present at the Jefferies 2nd

Annual Healthcare Conference in New York City. The presentation is

scheduled to begin at 3:45 p.m. ET.

Investors interested in listening to the live webcasts of these presentations should log on to the "Investor Relations" section of Cynosure's website,, and click on the link labeled "Events." The presentations also will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
2. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
3. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
6. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
7. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
8. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
9. Growing Generations Announces Surrogacy Program for Men with HIV
10. DRCs Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications
11. Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
Post Your Comments:
(Date:11/24/2015)...  Clintrax Global, Inc., a worldwide provider of clinical research services ... that the company has set a new quarterly earnings record in ... growth posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions ... Melanie Aregger to serve as Chief Operating Officer. , Having joined InSphero ... team and was promoted to Head of InSphero Diagnostics in 2014. There ...
(Date:11/24/2015)... VILLAGE, Nev. , Nov. 24, 2015  PDL BioPharma, ... John P. McLaughlin , the company,s president and chief executive ... Jaffray Healthcare Conference next week in New York ... will occur on Tuesday, December 1, 2015 at 9:30 a.m. ... Presentations." Please connect to the website at least 15 minutes ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
Breaking Biology News(10 mins):